scholarly journals Effects of sardine oil and milk lipids on oxidative stress and inflammation markers in diet-induced hypercholesterolaemic rats

2010 ◽  
Vol 69 (OCE3) ◽  
Author(s):  
F. Dehiba ◽  
A. Benyahia-Mostefaoui ◽  
H. M. Khelladi ◽  
A. Boualga ◽  
M. Y. Lamri-Senhadji ◽  
...  
Materials ◽  
2021 ◽  
Vol 14 (12) ◽  
pp. 3427
Author(s):  
Ievgeniia Kocherova ◽  
Artur Bryja ◽  
Katarzyna Błochowiak ◽  
Mariusz Kaczmarek ◽  
Katarzyna Stefańska ◽  
...  

Photobiomodulation (PBM), also called low-level laser treatment (LLLT), has been considered a promising tool in periodontal treatment due to its anti-inflammatory and wound healing properties. However, photobiomodulation’s effectiveness depends on a combination of parameters, such as energy density, the duration and frequency of the irradiation sessions, and wavelength, which has been shown to play a key role in laser-tissue interaction. The objective of the study was to compare the in vitro effects of two different wavelengths—635 nm and 808 nm—on the human primary gingival fibroblasts in terms of viability, oxidative stress, inflammation markers, and specific gene expression during the four treatment sessions at power and energy density widely used in dental practice (100 mW, 4 J/cm2). PBM with both 635 and 808 nm at 4 J/cm2 increased the cell number, modulated extracellular oxidative stress and inflammation markers and decreased the susceptibility of human primary gingival fibroblasts to apoptosis through the downregulation of apoptotic-related genes (P53, CASP9, BAX). Moreover, modulation of mesenchymal markers expression (CD90, CD105) can reflect the possible changes in the differentiation status of irradiated fibroblasts. The most pronounced results were observed following the third irradiation session. They should be considered for the possible optimization of existing low-level laser irradiation protocols used in periodontal therapies.


2016 ◽  
Vol 30 (12) ◽  
pp. 1988-2000 ◽  
Author(s):  
Sara A. Burt ◽  
Simone J.M. Adolfse ◽  
Dina S.A. Ahad ◽  
Monique H.G. Tersteeg‐Zijderveld ◽  
Betty G.M. Jongerius‐Gortemaker ◽  
...  

2017 ◽  
Vol 112 ◽  
pp. 130
Author(s):  
Beatriz Isabel García-Martínez ◽  
Juana Rosado-Pérez ◽  
Mirna Ruiz-Ramos ◽  
Víctor Manuel Mendoza-Núñez

2018 ◽  
Vol 9 (1) ◽  
pp. 463-475 ◽  
Author(s):  
Libia Alejandra García-Flores ◽  
Sonia Medina ◽  
Cristina Gómez ◽  
Craig E. Wheelock ◽  
Roberto Cejuela ◽  
...  

Linking aronia–citrus juice intake and oxidative stress and inflammation markers in physical activity framework.


Data in Brief ◽  
2016 ◽  
Vol 7 ◽  
pp. 460-467 ◽  
Author(s):  
Xiaolei Jin ◽  
Melanie Coughlan ◽  
Jennifer Roberts ◽  
Rekha Mehta ◽  
Jayadev Raju

Author(s):  
Entsar A Saad ◽  
Salem A. Habib ◽  
Wael A. Refai ◽  
Amira A. Elfayoumy

Objective: Great interest is directed to inflammation and oxidative stress involvement in type 2 diabetes pathogenesis. Many researchers suggest they play roles but exactly how is still not clear enough. This encouraged us to investigate relations and potential inter-relationships between them and insulin resistance in type 2 diabetes in its early stage. Whether metformin drug alone, as frequently prescribed, is enough for type 2 diabetes management in this early stage was an objective.Methods: Blood sugar indices, adiponectin (ADIPOQ), tumor necrosis factor-α (TNF-α), malondialdehyde (MDA), nitric oxide (NO), C-reactive protein (CRP), liver and kidney function tests and lipid profile were monitored in non-diabetic volunteers, pre-diabetic and newly diagnosed type 2 diabetic patients before and after metformin drug utilization for 5 mo.Results: MDA, inflammation markers and alanine aminotransferase (ALT) were elevated, and blood sugar indices and lipid profile showed pathological alterations in diabetics compared to non-diabetics; changes were worse in type 2 cases. They were improved to different degrees by metformin treatment except for pancreatic β-cells function and ADIPOQ level showed no significant improvements and it couldn’t normalize ALT.Conclusion: Results reflected significant relations and inter-relationships between oxidative stress and inflammation markers in type 2 diabetes in its early stage and indicated that metformin may need to be combined with another drug. 


2016 ◽  
Vol 2016 ◽  
pp. 1-13 ◽  
Author(s):  
Cristina Gluhovschi ◽  
Gheorghe Gluhovschi ◽  
Ligia Petrica ◽  
Romulus Timar ◽  
Silvia Velciov ◽  
...  

Diabetic nephropathy (DN) is a frequent and severe complication of diabetes mellitus (DM). Its diagnosis in incipient stages may allow prompt interventions and an improved prognosis. Towards this aim, biomarkers for detecting early DN can be used. Microalbuminuria has been proven a remarkably useful biomarker, being used for diagnosis of DN, for assessing its associated condition—mainly cardiovascular ones—and for monitoring its progression. New researches are pointing that some of these biomarkers (i.e., glomerular, tubular, inflammation markers, and biomarkers of oxidative stress) precede albuminuria in some patients. However, their usefulness is widely debated in the literature and has not yet led to the validation of a new “gold standard” biomarker for the early diagnosis of DN. Currently, microalbuminuria is an important biomarker for both glomerular and tubular injury. Other glomerular biomarkers (transferrin and ceruloplasmin) are under evaluation. Tubular biomarkers in DN seem to be of a paramount importance in the early diagnosis of DN since tubular lesions occur early. Additionally, biomarkers of inflammation, oxidative stress, podocyte biomarkers, and vascular biomarkers have been employed for assessing early DN. The purpose of this review is to provide an overview of the current biomarkers used for the diagnosis of early DN.


Sign in / Sign up

Export Citation Format

Share Document